Suchergebnisse - "Willke, Richard J"

PubPharm (101)

1

Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies

enthalten in: bioRxiv.org | 2023

von Fischer, R. | Furlong, P. | Kennedy, A. | +11

2

EUreccA 2025 : A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2023

von Pizzi, L. | Willke, R.

3

Incidence of mental health conditions by seizure control among adults with epilepsy in the United States

enthalten in: Epilepsy & behavior : E&B | 2022

von Schabert, V. | Stern, S. | Ferrari, L. | +3

4

The History and Future of the "ISPOR Value Flower" : Addressing Limitations of Conventional Cost-Effectiveness Analysis

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Neumann, P. | Garrison, L. | Willke, R.

5

CHEERS to Updated Guidelines for Reporting Health Economic Evaluations!

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2022

von Willke, R. | Pizzi, L.

6

Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials

enthalten in: BMC medicine | 2021

von Hong, Y. | Jansen, J. | Guerino, J. | +6

7

Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials

enthalten in: BMC medicine | 2021

von Hong, Y. | Jansen, J. | Guerino, J. | +6

8

Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug Development

enthalten in: Clinical pharmacology and therapeutics | 2021

von Hill-McManus, D. | Marshall, S. | Liu, J. | +2

9

Improving transparency to build trust in real-world secondary data studies for hypothesis testing-Why, what, and how : recommendations and a road map from the real-world evidence transparency initiative

enthalten in: Pharmacoepidemiology and drug safety | 2020

von Orsini, L. | Monz, B. | Mullins, C. | +13

10

Improving Transparency to Build Trust in Real-World Secondary Data Studies for Hypothesis Testing-Why, What, and How : Recommendations and a Road Map from the Real-World Evidence Transparency Initiative

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2020

von Orsini, L. | Berger, M. | Crown, W. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]